Rajeev Krishnadas,Emilio Fernandez-Egea
Rajeev Krishnadas
Clozapine is a pharmacological treatment with strong evidence for treatment-resistant schizophrenia (TRS), yet it continues to be under-prescribed, initiated late, and offered to a minority of eligible patients. This treatment gap is felt m...
Ultra-Treatment-Resistant Schizophrenia: Unmet Needs and a Critical Opportunity for Discovery [0.03%]
超耐药性 schizophrenia:未满足的需求和发现的critical机会
Frederick C Nucifora Jr,Deepak K Sarpal,Russell L Margolis
Frederick C Nucifora Jr
Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial [0.03%]
一项随机对照试验:酮体饮食代谢改善与精神病症状改善相关性研究
Samantha V Abram,Juliette M Kyner,An Vu et al.
Samantha V Abram et al.
Background and hypothesis: Psychiatric medications contribute to high rates of metabolic dysfunction in psychotic disorders. Ketogenic diets reduce metabolic syndrome, have anticonvulsant effects in epilepsy, and may impr...
Randomized Controlled Trial
Schizophrenia bulletin. 2026 Jul 3;52(4):sbag082. DOI:10.1093/schbul/sbag082 2026
Faith B Dickerson
Faith B Dickerson
The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients [0.03%]
司美格鲁肽对住院精神疾病患者抗精神病药物所致体重增加及其他代谢参数的影响
Riddhita De,Yasser Amin Alfatwa,Pruntha Kanagasundaram et al.
Riddhita De et al.
Background and hypothesis: Antipsychotic use in severe mental illnesses (SMI) is associated with metabolic dysregulation, including antipsychotic-induced weight gain (AIWG), type 2 diabetes (T2D), and dyslipidemia. In the...
Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis [0.03%]
速度之外:D2受体亲和力预测首次发作精神病在抗精神病药物减量后的复发
Shiral S Gangadin,Franciska de Beer,Iris E Sommer
Shiral S Gangadin
Correction to: The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry [0.03%]
对《迷你CAARMS:综合高危精神状态评估量表的简化版编制及其效度研究》一文的更正
Published Erratum
Schizophrenia bulletin. 2026 Apr 10;52(3):sbag108. DOI:10.1093/schbul/sbag108 2026
Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis [0.03%]
首发精神病患者体重、多基因风险评分与出生体重对血糖和抗精神病药物致体重增加的纵向影响研究
Nora Guasch-Capella,Patricia Gassó,Miquel Bioque et al.
Nora Guasch-Capella et al.
Background and hypothesis: Patients with first-episode psychosis (FEP) frequently experience early metabolic alterations, including antipsychotic-induced weight gain (AIWG) and fasting glucose dysregulation. Birth weight ...
Renato de Filippis,Pasquale De Fazio
Renato de Filippis
Clozapine remains an unparalleled antipsychotic nearly seven decades after its synthesis, distinguished by superior efficacy in treatment-resistant schizophrenia and a unique anti-suicidal effect, alongside a complex profile of adverse even...